🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to investigate the effectiveness of PNF and conve...
Status
Completed
Location
Gulf Medical University
Start Date
2023-02-16
Trial ID
NCT06605456
This study is open to adults with diabetic macular edema that involves the ...
Status
Recruiting
Location
Associated Retina Consultants, Ltd.
Start Date
2026-05-14
Trial ID
NCT07553429
Treatments Being Tested
The overall aim of the study is to establish bioequivalence between commerc...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-05
Trial ID
NCT01599377
Treatments Being Tested
This Phase I study is to investigate the safety of two dose levels of NFL-1...
Status
Completed
Location
Institut du Cancer de Montpellier - Val d'Aurelle
Start Date
2014-12
Trial ID
NCT02521701
Treatments Being Tested
This phase I trial studies the side effects and best dose of AR-42 when giv...
Status
Completed
Location
Cincinnati Children's Hospital
Start Date
2013-09-17
Trial ID
NCT01798901
Treatments Being Tested
Randomized, placebo-controlled, double-blind, parallel design, Phase 3 stud...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2009-09
Trial ID
NCT01037244
RATIONALE: Providing information that is tailored to answer patients' quest...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2008-04
Trial ID
NCT00750009
Treatments Being Tested
This is a multicenter, open-label, evaluator-blinded, investigator-initiate...
Status
Completed
Location
Beijing Tian tan Hospital
Start Date
2024-03-11
Trial ID
NCT06064734
Treatments Being Tested
There will be 2 phases in this study. Patients will either be enrolled to t...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2006-09
Trial ID
NCT00402116
Treatments Being Tested
This is a Phase 1, open-label, randomized, PK and safety study in a maximum...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2018-11-26
Trial ID
NCT03691584
Treatments Being Tested